O'Byrne Patrick, Friedman Dara Spatz, Orser Lauren
School of Nursing, University of Ottawa, Ottawa, Ontario, Canada.
Ottawa Public Health, Ottawa, Ontario, Canada.
BMJ Public Health. 2025 Jul 30;3(2):e002661. doi: 10.1136/bmjph-2025-002661. eCollection 2025.
Increases in bacterial sexually transmitted infections (bac-STIs), such as gonorrhoea, chlamydia and syphilis, have affected gay, bisexual, and other men who have sex with men (gbMSM). A new strategy to prevent bac-STIs involves giving doxycycline as postexposure prophylaxis (doxy-PEP), and research shows that this intervention can prevent chlamydia and syphilis by 70% and gonorrhoea by 33%-50%. Consequently, the US CDC released guidelines in 2024 recommending doxy-PEP for gbMSM with ≥1 bacterial STI diagnosis in the previous 12 months.
We reviewed public health STI surveillance data between 1 January 2021 and 31 December 2024 for gbMSM in Ottawa, Canada, and analysed the number of infections and episodes of infections per person. We estimated the number of individuals who would need doxy-PEP to prevent a single bac-STI episode.
During the study period, 1819 unique gbMSM experienced 2834 positive bac-STI testing episodes (PTE), during which 3114 bac-STIs were diagnosed. Consistently, three-quarters of gbMSM did not have a subsequent infection, whether they were diagnosed with 1 infection, 2 infections or ≥3. Considering the average effectiveness of doxy-PEP in this study population, the average number needed to treat (NNT) if doxy-PEP were prescribed to all gbMSM to prevent a first PTE would have been 60. The NNT among those with their first PTE to prevent a second PTE was 8; among those with their second, the NNT was 7.
Based on these data, and in alignment with the CDC guidelines, we conclude that doxy-PEP would likely have the most balanced population-level bac-STI prevention effect if given to gbMSM with ≥1 bac-STI diagnosis within the preceding 12 months. Providing doxy-PEP to all gbMSM would likely result in an overuse of antibiotics, and providing doxy-PEP only after a second PTE would result in fewer infections averted for the same proportion treated.
淋病、衣原体感染和梅毒等细菌性性传播感染(bac-STIs)的增加影响了男同性恋、双性恋和其他与男性发生性行为的男性(gbMSM)。一种预防bac-STIs的新策略是给予多西环素进行暴露后预防(doxy-PEP),研究表明这种干预措施可将衣原体感染和梅毒的预防率提高70%,淋病的预防率提高33%-50%。因此,美国疾病控制与预防中心(CDC)在2024年发布了指南,建议对在过去12个月内有≥1次细菌性性传播感染诊断的gbMSM采用doxy-PEP。
我们回顾了2021年1月1日至2024年12月31日期间加拿大渥太华gbMSM的公共卫生性传播感染监测数据,并分析了感染人数和每人的感染发作次数。我们估计了需要接受doxy-PEP以预防单次bac-STI发作的个体数量。
在研究期间,1819名不同的gbMSM经历了2834次细菌性性传播感染阳性检测事件(PTE),在此期间诊断出3114例bac-STIs。一致的是,无论gbMSM被诊断出1次感染、2次感染还是≥3次感染,四分之三的人都没有后续感染。考虑到本研究人群中doxy-PEP的平均有效性,如果对所有gbMSM都开具doxy-PEP以预防首次PTE,平均治疗所需人数(NNT)将为60。首次发生PTE的人群中预防第二次PTE的NNT为8;第二次发生PTE的人群中,NNT为7。
基于这些数据,并与CDC指南一致,我们得出结论,如果对在过去12个月内有≥1次bac-STI诊断的gbMSM给予doxy-PEP,在人群层面上可能具有最平衡的bac-STI预防效果。对所有gbMSM提供doxy-PEP可能会导致抗生素的过度使用,而仅在第二次PTE后提供doxy-PEP,对于相同比例的治疗人群,避免的感染将减少。